Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach

Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach Key Takeaways The alopecia areata treatment landscape has transformed dramatically, moving beyond ineffective steroid-only approaches to targeted immune therapies that offer real hope for patients with severe hair loss. Three FDA-approved JAK inhibitors are

VEXAS Syndrome: The Newly Discovered Disorder Every Hematologist Should Know

VEXAS Syndrome: The Newly Discovered Disorder Every Hematologist Should Know   Check back later for a possible video summary. Videos are created for most articles. Abstract This paper provides a comprehensive review of VEXAS syndrome; a newly recognized, adult-onset autoinflammatory condition with a genetic basis and complex multisystem involvement, carrying significant implications for hematologists, rheumatologists, and other specialists. First

Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach